Search Results 1451-1460 of 16905 for Rebound+insomnia
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
This partially randomized phase III trial studies the side effects of inotuzumab ozogamicin and how well it works when given with frontline chemotherapy in ...
The purpose of this study is to collect and store cerebrospinal fluid (CSF)from patients with normal CSF. This stored CSF will be used in the future as a ...
This short bout of stroke-like symptoms doesn't cause permanent damage. But it may serve as a warning sign of a future stroke.
Mayo Clinic doctors trained in nervous system conditions (neurology) and other areas conduct extensive research in movement disorders. Researchers study ...
This is a 3-day study comparing pyridostigmine versus placebo in the treatment of postural tachycardia syndrome (POTS). The researchers expect pyridostigmine to ...
The purpose of this study is to compare the safety and effectiveness of Lusedra with the current standard of care (midazolam) for minimal to moderate sedation, ...
The purpose of phase 1 of this trial is to determine the maximum tolerated dose of temozolomide followed by selinexor in recurrent glioblastoma patients as ...
The purpose of this study is to measure overall activity (sedentary-to-high intensity) during rehab and at 1 year follow-up. Participation eligibility.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!